DUBLIN--(BUSINESS WIRE)--The "NGS-based RNA-seq - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
NGS-based RNA-seq market worldwide is projected to grow by US$3.3 Billion, driven by a compounded growth of 20.7%.
Sample Preparation, one of the segments analyzed and sized in this study, displays the potential to grow at over 16.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$893.9 Million by the year 2025, Sample Preparation will bring in healthy gains adding significant momentum to global growth.
Representing the developed world, the United States will maintain a 22.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$129.5 Million to the region's size and clout in the next 5 to 6 years. Over US$158.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Sample Preparation will reach a market size of US$86.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 20.4% over the next couple of years and add approximately US$589.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others,
- Agilent Technologies, Inc.
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- GATC Biotech AG
- Illumina, Inc.
- Macrogen, Inc.
- Oxford Nanopore Technologies Ltd.
- Pacific Biosciences of California, Inc.
- PerkinElmer, Inc.
- Qiagen NV
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- RNA-Seq: An Introduction
- A Prelude to NGS-based RNA-seq Market
- North America: The Largest Market for NGS-based RNA-seq
- Global Competitor Market Shares
- NGS-based RNA-seq Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- NGS-based RNA-seq Market Drivers and Restraints
- Recent Advances in RNA Sequence Analysis
- Select Players of NGS-based RNA-seq Market
- Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique
- Application of RNA-Seq in Precision Medicine
- Next Generation Sequencing in Cancer Research
- Next Generation Sequencing for Transcriptomic Profiling
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
- Market Facts & Figures
- US NGS-based RNA-seq Market Share (in %) by Company: 2019 & 2025
- Market Analytics
CANADA
JAPAN
CHINA
EUROPE
- Market Facts & Figures
- European NGS-based RNA-seq Market: Competitor Market Share Scenario (in %) for 2019 & 2025
- Market Analytics
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
IV. COMPETITION
V. CURATED RESEARCH
For more information about this report visit https://www.researchandmarkets.com/r/g7oc7
